Short answer
EyePoint, Inc. (EYPT) filed an 8-K current report with the SEC on July 17, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). $4.68 million settlement plus 4.25% interest for alleged DEXYCU sales and marketing violations.
EyePoint, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $4.68 million settlement plus 4.25% interest for alleged DEXYCU sales and marketing violations
- Additional $166,500 attorneys’ fees, payable within 60 days
- Cash-on-hand funding limits immediate liquidity impact but creates a near-term cash outflow
- Five-year Corporate Integrity Agreement adds compliance costs and operational oversight through July 13, 2031
- Medicare and Medicaid exclusion avoided, preserving access to federal healthcare programs conditioned on compliance
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other EyePoint, Inc. 8-K filings
Get the next EYPT 8-K as it lands
Follow EYPT for push alerts, or ask the research agent what this filing means.